Since 2001, Maersk has been offering global pharmaceutical players in Central Europe professional warehousing and distribution services specifically tailored to meet the needs of this demanding customer segment. To further build on this experience and address growing customer needs, Maersk is launching a project to create a second pharmaceutical warehouse as part of its existing warehousing and distribution centre in Mszczonow (Poland), expected to be operational by end of June 2021.
Equipped with a modern, state-of-the-art temperature controlling system that will ensure the safety of sensitive cargo, the new building will be to a large extent powered by renewable energy, ensuring its sustainability and carbon neutrality. The facility will have integrated Quality Management System implemented, based on Good Distribution and Manufacturing Practice (GDP) and ISO certificates.
The warehouse will be an addition to Maersk’s already existing own warehousing and distribution centre in Mszczonow (Poland), which has dedicated sections for human and animal health products and will be operated by a staff of experts in logistics needs of this customer group.
“In such an industry, quality plays a pivotal role and it can only be guaranteed by experienced and competent personnel who have a thorough understanding of specific requirements of pharmaceutical customers”, shares Jakub Mach, Ph.D., Country Cold Chain Logistics Manager at Maersk in Poland. “In that sense, the new project is equally important for the additional warehousing space we will bring to the market, as it is for the capabilities of our people involved in daily operations”.
The new warehousing and distribution centre will in addition offer repacking capabilities, as well as professional transportation services in different temperature ranges (ambient, cold, liquid nitrogen and dry ice) based on a validated Transport Management System.
